Start Forschung Publikationen Publikationen

Publikationen

Zitate durchsuchen

2019

 
Aggensteiner PM, Brandeis D, Millenet S, Hohmann S, Ruckes C, Beuth S, Albrecht B, Schmitt G, Schermuly S, Wörz S, Gevensleben H, Freitag CM, Banaschewski T, Rothenberger A, Strehl U, Holtmann M. Slow cortical potentials neurofeedback in children with ADHD: comorbidity, self-regulation and clinical outcomes 6 months after treatment in a multicenter randomized controlled trial. Eur Child Adolesc Psychiatry 2019 Jan 4. [Epub ahead of print]
Albaugh MD, Hudziak JJ, Ing A, Chaarani B, Barker E, Jia T, Lemaitre H, Watts R, Orr C, Spechler PA, Lepage C, Fonov V, Collins L, Rioux P, Evans AC, Banaschewski T, Bokde AL, Bromberg U, Büchel C, Quinlan EB, Desrivieres S, Flor H, Frouin V, Gowland P, Heinz A, Ittermann B, Martinot JL, Nees F, Orfanos DP, Paus T, Poustka L, Fröhner JH, Smolka MN, Walter H, Whelan R, Schumann G, Garavan H, Potter A. White matter microstructure is associated with hyperactive/inattentive symptomatology and polygenic risk for attention-deficit/hyperactivity disorder in a population-based sample of adolescents. Neuropsychopharmacology 2019 Apr 6. [Epub ahead of print]
Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, Bettella F, Agartz I, Barch DM, Bertolino A, Brandt CL, Cervenka S, Djurovic S, Doan NT, Eisenacher S, Fatouros-Bergman H, Flyckt L, Di Giorgio A, Haatveit B, Jönsson EG, Kirsch P, Lund MJ, Meyer-Lindenberg A, Pergola G, Schwarz E, Smeland OB, Quarto T, Zink M, Andreassen OA, Westlye LT, Karolinska Schizophrenia Project Consortium . Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk. JAMA Psychiatry 2019 Apr 10. [Epub ahead of print]
Anderson-Schmidt H, Gade K, Malzahn D, Papiol S, Budde M, Heilbronner U, Reich-Erkelenz D, Adorjan K, Kalman JL, Senner F, Comes AL, Flatau L, Gryaznova A, Hake M, Reitt M, Schmauß M, Juckel G, Reimer J, Zimmermann J, Figge C, Reininghaus E, Anghelescu IG, Konrad C, Thiel A, von Hagen M, Koller M, Stierl S, Scherk H, Spitzer C, Folkerts H, Becker T, Dietrich DE, Andlauer TFM, Degenhardt F, Nöthen MM, Witt SH, Rietschel M, Wiltfang J, Falkai P, Schulze TG. The influence of religious activity and polygenic schizophrenia risk on religious delusions in schizophrenia. Schizophr Res 2019 Jan 3. [Epub ahead of print]
Aubin HJ, Mann K. Medication development: reducing casualties in the valley of death and providing support for survivors. Alcohol Clin Exp Res 2019 43(1):22-52. Epub 2018 Nov 11.
Bach P, Bumb JM, Schuster R, Vollstädt-Klein S, Reinhard I, Rietschel M, Witt SH, Wiedemann K, Kiefer F, Koopmann A. Effects of leptin and ghrelin on neural cue-reactivity in alcohol addiction: Two streams merge to one river?. Psychoneuroendocrinology 2019 100:1-9. Epub 2018 Sep 18.
Bach P, Frischknecht U, Bungert M, Karl D, Vollmert C, Vollstädt-Klein S, Lis S, Kiefer F, Hermann D. Effects of social exclusion and physical pain in chronic opioid maintenance treatment: fMRI correlates. Eur Neuropsychopharmacol 2019 29(2):291-305. Epub 2018 Nov 27.
Bach P, Weil G, Pompili E, Hoffmann S, Hermann D, Vollstädt-Klein S, Mann K, Perez-Ramirez U, Moratal D, Canals S, Dursun SM, Greenshaw AJ, Kirsch P, Kiefer F, Sommer WH. Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone. Addict Biol 2019 Feb 12. [Epub ahead of print]
Bach P, Zois V, Vollstädt-Klein S, Kirsch M, Hoffmann S, Jorde A, Frank J, Charlet K, Treutlein J, Beck A, Heinz A, Walter H, Rietschel M, Kiefer F. Association of the alcohol dehydrogenase gene polymorphism rs1789891 with gray matter brain volume, alcohol consumption, alcohol craving and relapse risk. Addict Biol 2019 24(1):110-120. Epub 2017 Oct 23.
Baker TE, Castellanos-Ryan N, Schumann G, Cattrell A, Flor H, Nees F, Banaschewski T, Bokde A, Whelan R, Buechel C, Bromberg U, Papadopoulos Orfanos D, Gallinat J, Garavan H, Heinz A, Walter H, Brühl R, Gowland P, Paus T, Poustka L, Martinot JL, Lemaitre H, Artiges E, Paillère Martinot ML, Smolka MN, Conrod P, IMAGEN consortium . Modulation of orbitofrontal-striatal reward activity by dopaminergic functional polymorphisms contributes to a predisposition to alcohol misuse in early adolescence. Psychol Med 2019 49(5):801-810. Epub 2018 Jun 18.
Baldofski S, Kohls E, Bauer S, Becker K, Bilic S, Eschenbeck H, Kaess M, Moessner M, Salize HJ, Diestelkamp S, Voss E, Rummel-Kluge C, ProHEAD consortium . Efficacy and cost-effectiveness of two online interventions for children and adolescents at risk for depression (E.motion trial): study protocol for a randomized controlled trial within the ProHEAD consortium. Trials 2019 20(1):53.
Banaschewski T. Einladung zum XXXVI. DGKJP-Kongress. Z Kinder Jugendpsychiatr Psychother 2019 47(2):101-102.
Bauer S, Bilic S, Reetz C, Ozer F, Becker K, Eschenbeck H, Kaess M, Rummel-Kluge C, Salize H, Diestelkamp S, Moessner M, ProHEAD Consortium . Efficacy and cost-effectiveness of Internet-based selective eating disorder prevention: study protocol for a randomized controlled trial within the ProHEAD Consortium. Trials 2019 20(1):91.
Baumeister S, Wolf I, Hohmann S, Holz N, Boecker-Schlier R, Banaschewski T, Brandeis D. The impact of successful learning of self-regulation on reward processing in children with ADHD using fMRI. Atten Defic Hyperact Disord 2019 11(1):31-45. Epub 2018 Sep 17.
Becker C, Schmidt S, Neuberger EWI, Kirsch P, Simon P, Dettweiler U. Children's Cortisol and Cell-Free DNA Trajectories in Relation to Sedentary Behavior and Physical Activity in School: A Pilot Study. Front Public Health 2019 7:26.
Bin Wei Y, McCarthy M, Ren H, Carrillo-Roa T, Shekhtman T, DeModena A, Liu JJ, Leckband SG, Mors O, Rietschel M, Henigsberg N, Cattaneo A, Binder EB, Aitchison KJ, Kelsoe JR. A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression. Mol Psychiatry 2019 Mar 15. [Epub ahead of print]
Böge K, Karnouk C, Hahn E, Schneider F, Habel U, Banaschewski T, Meyer-Lindenberg A, Salize HJ, Kamp-Becker I, Padberg F, Hasan A, Falkai P, Rapp MA, Plener PL, Stamm T, Elnahrawy N, Lieb K, Heinz A, Bajbouj M. Mental health in refugees and asylum seekers (MEHIRA): study design and methodology of a prospective multicentre randomized controlled trail investigating the effects of a stepped and collaborative care model. Eur Arch Psychiatry Clin Neurosci 2019 Feb 22. [Epub ahead of print]
Bohus M, Schmahl C, Fydrich T, Steil R, Müller-Engelmann M, Herzog J, Ludascher P, Kleindienst N, Priebe K. A research programme to evaluate DBT-PTSD, a modular treatment approach for Complex PTSD after childhood abuse. BPDED 2019 6:7.
Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleo A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum. Alzheimers Dement 2019 Mar 7. [Epub ahead of print]
Brislin SJ, Patrick CJ, Flor H, Nees F, Heinrich A, Drislane LE, Yancey JR, Banaschewski T, Bokde AL, Bromberg U, Büchel C, Quinlan EB, Desrivieres S, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Martinot JL, Martinot MP, Papadopoulos Orfanos D, Poustka L, Fröhner JH, Smolka MN, Walter H, Whelan R, Conrod P, Stringaris A, Struve M, van Noort B, Grimmer Y, Fadai T, Schumann G, Foell J. Extending the Construct Network of Trait Disinhibition to the Neuroimaging Domain: Validation of a Bridging Scale for Use in the European IMAGEN Project. Assessment 2019 26(4):567-581. Epub 2018 Mar 20.
Brown D, Nakagome K, Cordes J, Brenner R, Gründer G, Keefe RSE, Riesenberg R, Walling DP, Daniels K, Wang L, McGinniss J, Sand M. Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. Schizophr Bull 2019 45(2):350-359. Epub 2018 May 1.
Brünen S, Bekier N, Hiemke C, Korf F, Wiedemann K, Jahn H, Kiefer F. Therapeutic Drug Monitoring of Naltrexone and 6β-Naltrexol During Anti-craving Treatment in Alcohol Dependence: Reference Ranges. Alcohol Alcohol 2019 54(1):51-55. Epub 2018 Sep 27.
Bruns B, Schmitz T, Diemert N, Schwale C, Werhahn SM, Weyrauther F, Gass P, Vogt MA, Katus H, Herzog W, Backs J, Schultz JH. Learned helplessness reveals a population at risk for depressive-like behaviour after myocardial infarction in mice. ESC Heart Fail 2019 Apr 26. [Epub ahead of print]
Budde M, Anderson-Schmidt H, Gade K, Reich-Erkelenz D, Adorjan K, Kalman JL, Senner F, Papiol S, Andlauer TFM, Comes AL, Schulte EC, Klöhn-Saghatolislam F, Gryaznova A, Hake M, Bartholdi K, Flatau L, Reitt M, Quast S, Stegmaier S, Meyers M, Emons B, Haußleiter IS, Juckel G, Nieratschker V, Dannlowski U, Schaupp SK, Schmauß M, Zimmermann J, Reimer J, Schulz S, Wiltfang J, Reininghaus E, Anghelescu IG, Arolt V, Baune BT, Konrad C, Thiel A, Fallgatter AJ, Figge C, von Hagen M, Koller M, Lang FU, Wigand ME, Becker T, Jäger M, Dietrich DE, Stierl S, Scherk H, Spitzer C, Folkerts H, Witt SH, Degenhardt F, Forstner AJ, Rietschel M, Nöthen MM, Falkai P, Schulze TG, Heilbronner U. A longitudinal approach to biological psychiatric research: The PsyCourse study. Am J Med Genet B Neuropsychiatr Genet 2019 180(2):89-102. Epub 2018 Aug 2.
Budde M, Friedrichs S, Alliey-Rodriguez N, Ament S, Badner JA, Berrettini WH, Bloss CS, Byerley W, Cichon S, Comes AL, Coryell W, Craig DW, Degenhardt F, Edenberg HJ, Foroud T, Forstner AJ, Frank J, Gershon ES, Goes FS, Greenwood TA, Guo Y, Hipolito M, Hood L, Keating BJ, Koller DL, Lawson WB, Liu C, Mahon PB, McInnis MG, McMahon FJ, Meier SM, Mühleisen TW, Murray SS, Nievergelt CM, Nurnberger JI, Nwulia EA, Potash JB, Quarless D, Rice J, Roach JC, Scheftner WA, Schork NJ, Shekhtman T, Shilling PD, Smith EN, Streit F, Strohmaier J, Szelinger S, Treutlein J, Witt SH, Zandi PP, Zhang P, Zöllner S, Bickeböller H, Falkai PG, Kelsoe JR, Nöthen MM, Rietschel M, Schulze TG, Malzahn D. Efficient region-based test strategy uncovers genetic risk factors for functional outcome in bipolar disorder. Eur Neuropsychopharmacol 2019 29(1):156-170. Epub 2018 Nov 29.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de